Considerations in the pharmacotherapy of bipolar disorder during and after pregnancy

Current Drug Safety

Volumn 6, Issue 5, 2011, Pages 318-323

  Sharma, Verinder ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bipolar disorder; Lactation; Pharmacotherapy; Postpartum; Pregnancy; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BROMOCRIPTINE; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; PSEUDOEPHEDRINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID; ZIPRASIDONE;

ANXIETY; ARTICLE; BIPOLAR DISORDER; BREAST FEEDING; CHILDBIRTH; COMORBIDITY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GAIT DISORDER; HEADACHE; HEALTH; HEALTH STATUS; HUMAN; INSOMNIA; IRRITABILITY; MAJOR DEPRESSION; NAUSEA; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOSIS; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; RAPID CYCLING BIPOLAR DISORDER; RELAPSE; SHOCK; SIDE EFFECT; SUICIDE; TERATOGENICITY; TREMOR; VERTIGO; VISUAL DISORDER; VOMITING;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BREAST FEEDING; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84855829391     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488611798918656     Document Type: Article

References (40)

1. Benazzi F. Gender differences in bipolar-II disorder. Eur Arch Psychiatry Clin Neurosci 2006; 256: 67-71.
2. Merkikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64: 543-42.
3. Calabrese JR., Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: Results of a U.S. community-based sample. J Clin Psychiatry 2004; 65: 1499-1504.
4. Murray C, Lopez A, Eds. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Edited by Anonymous Cambridge, Harvard University Press 1996.
5. Viguera A, Nonacs R, Cohen L, Tondo L. Murray A. Baldessarini R. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157: 179-84.
6. Grof P, Robbins W, Alda M, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord. 2000; 61: 31-39.
7. Viguera A, Whitfeld T, Baldessarini R, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164: 1817-24.
8. Newport DJ, Stowe ZN, Viguera A, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008; 10: 432-6.
9. Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. Am J Psychiatry 2003; 64: 1284-92.
10. Brockington I, Margison F, Schofield E, Knight R. The clinical picture of the depressed form of puerperal psychosis. J Affect Disord. 1998; 15: 29-37.
11. Munk-Olsen T, Laursen T, Mendelson T, Pederson C, Mors O, Mortensen P. Family and partner psychopathology and the risk of postpartum mental disorders. Arch Gen Psychiatry 2009; 68: 1947-53.
12. Yonkers K, Wisner K, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161: 608-20.
13. Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010; 36: 518-44.
14. Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009; 15: 183-92.
15. Nguyen HTT, Sharma V, McIntyre RS. Teratogenesis associated with antibipolar agents. Adv Ther 2009; 26: 281-94.
16. Cohen L, Sichel D, Robertson L, Heckscher E, Rosenbaum J. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995; 152: 1641-45.
17. Wisner KL, Peindl K, Hanusa. Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic study. J Affect Disord 1993; 28: 39-50.
18. Sharma V, Smith A, Mazmanian D. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disord 2006; 8: 400-404.
19. Sharma V, Khan M, Corpse C, Sharma P. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord 2008; 10: 742-47.
20. Sharma V, Khan M. Identification of bipolar disorder in women with postpartum depression. Bipolar Disord 2010; 12: 335-40.
21. Sharma V, Xie B. Screening for postpartum bipolar disorder: Validation of the Mood Disorder Questionnaire. J Affect Disord 2011; 131: 408-11.
22. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 2006; 67, 1285-98.
23. Albacar G, Sans T, Martin-Santos R, et al. An association between plasma ferritin concentrations measured 48h after delivery and postpartum depression. J Affect Disord 2011; 131: 136-42.
24. Reeves RR, Pinkosky HB. Postpartum psychosis induced by bromocriptine and pseudoephedrine. J Fam Pract 1997; 45: 164-66.
25. Wisner KL, Hanusa BH, Peindl KS, Perel JM. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry 2004; 56: 592-6.
26. Viguera A, Koukopoulos A, Muzina D, Baldessarini R. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry 2007; 68: 29-33.
27. Llewellyn A, Stowe Z, Strader Jr. J. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998; 59: 57-64.
28. Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: Implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162: 2162-70.
29. Food and Drug Administration. Antipsychotic drugs: class labeling change-treatment during pregnancy and potential risk to new-borns. Last Update Feb 2, 2011. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm244175.htm. Accessed Sep 27, 2011.
30. Sharma V. Antidepressant use and postpartum psychosis. German J Psychiatry 2011; 14: 51-4.
31. Ghaemi S, Rosenquist K, Ko J, Baldassano C, Kontos N, Baldessarini R. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161: 163-65.
32. Sharma V, Khan M, Smith, A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J Affect Disord 2005; 84: 251-57.
33. Akiskal H, Benazzi M, Perugi G, Rihmer Z. Agitated unipolar depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 2005; 85: 245-58.
34. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnositc criteria. J Psychiatry Neurosci 2000; 25: 255-261.
35. Malm H, Artama M, Gissler M, Ritvanen A. Selective serotonin reuptake inhibitors and risk for major congential anomalies. Obstet Gynecol 2011; 118: 111-20.
36. Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009; 54: 242-6.
37. Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri D, Baldessarini RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. 2011 [Epub ahead of print].
38. Sharma V, Penava D. Screening for bipolar disorder during pregnancy and the postpartum period. J Obstet Gynaecol Can 2010; 32: 278-81.
39. Kennedy S, Lam R, Parikh S, Patten S, Ravindran A. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinicial guidelines for the management of major depressive disorder in adults. J Affect Disord 2009; 117: S1-S2.
40. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111: 1001-20.